These results, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 assist the strategy of focusing on ACKR3 as a singular technique to modulate the opioid process, which could open new therapeutic avenues for opioid-associated Issues.Be aware: Results may possibly differ ab